Guoping Ren

Hangzhou, 310000, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 51 publications

Primary prostatic yolk sac tumor: A rare case report and literature review.

Primary prostatic yolk sac tumor: A rare case report and literature review.

Journal: Urology case reports
Published: January 25, 2026

RB1 and p53 are diagnostic markers for treatment-related neuroendocrine prostate cancer: a clinical and pathological analysis of 23 cases.

RB1 and p53 are diagnostic markers for treatment-related neuroendocrine prostate cancer: a clinical and pathological analysis of 23 cases.

Journal: American journal of clinical and experimental urology
Published: February 28, 2025

UHRF1 and NF-κB signaling in prostate cancer progression insights from bioinformatics and experimental validation.

UHRF1 and NF-κB signaling in prostate cancer progression insights from bioinformatics and experimental validation.

Journal: BMC cancer
Published: February 07, 2025

Cribiform and intraductal carcinoma in hereditary prostate cancer: clinical and pathological analysis of 20 cases.

Cribiform and intraductal carcinoma in hereditary prostate cancer: clinical and pathological analysis of 20 cases.

Journal: American journal of clinical and experimental urology
Published: March 12, 2024

CCDC50, an essential driver involved in tumorigenesis, is a potential severity marker of diffuse large B cell lymphoma.

CCDC50, an essential driver involved in tumorigenesis, is a potential severity marker of diffuse large B cell lymphoma.

Journal: Annals of hematology
Published: May 12, 2023

Comparison of the clinicopathologic features of prostate cancer in US and Chinese populations.

Comparison of the clinicopathologic features of prostate cancer in US and Chinese populations.

Journal: Pathology, research and practice
Published: March 05, 2022

Identification of novel biomarkers differentially expressed between African-American and Caucasian-American prostate cancer patients.

Identification of novel biomarkers differentially expressed between African-American and Caucasian-American prostate cancer patients.

Journal: American journal of cancer research
Published: October 19, 2021

Dual block HER2 assessment increased HER2 immunohistochemistry positive rate in resected specimens of gastric cancer: a prospective multicenter clinical trial from China.

Dual block HER2 assessment increased HER2 immunohistochemistry positive rate in resected specimens of gastric cancer: a prospective multicenter clinical trial from China.

Journal: Diagnostic pathology
Published: September 27, 2021

KIF23 is a potential biomarker of diffuse large B cell lymphoma: Analysis based on bioinformatics and immunohistochemistry.

KIF23 is a potential biomarker of diffuse large B cell lymphoma: Analysis based on bioinformatics and immunohistochemistry.

Journal: Medicine
Published: August 07, 2021

Expression of 5-methylcytosine regulators is highly associated with the clinical phenotypes of prostate cancer and DNMTs expression predicts biochemical recurrence.

Expression of 5-methylcytosine regulators is highly associated with the clinical phenotypes of prostate cancer and DNMTs expression predicts biochemical recurrence.

Journal: Cancer medicine
Published: March 06, 2021

The Transcriptomic Landscape of Prostate Cancer Development and Progression: An Integrative Analysis.

The Transcriptomic Landscape of Prostate Cancer Development and Progression: An Integrative Analysis.

Journal: Cancers
Published: December 21, 2020

Identification of UBE2C as hub gene in driving prostate cancer by integrated bioinformatics analysis.

Identification of UBE2C as hub gene in driving prostate cancer by integrated bioinformatics analysis.

Journal: PloS one
Published: August 22, 2020
Showing 1-12 of 51

Last Updated: 09/26/2026